Plasma Proteome-Wide Mendelian Randomization Analysis Reveals Biomarkers and Therapeutic Targets for Different Stages of COVID-19

Table 3

Potential causal proteins for hospitalized COVID-19 identified in the cis- and pan-analyses.

Protein	Odds ratio	95% CI	P value	Cis/pan
BGAT	1.086	1.052–1.122	5.147e-07	Cis
NSF	0.545	0.416–0.714	1.107e-05	Cis
KLC1	1.635	1.303–2.052	2.148e-05	Cis
Myeloperoxidase	0.881	0.830–0.935	2.712e-05	Cis
PCNP	0.620	0.493–0.779	4.237e-05	Cis
CACO2	0.637	0.507–0.800	1.041e-04	Cis
STAT3	0.738	0.631–0.864	1.497e-04	Cis
MRVI1	0.727	0.616–0.858	1.678e-04	Cis
NSF	0.541	0.406–0.721	2.642e-05	Pan
PCNP	0.620	0.493–0.779	4.237e-05	Pan